Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02358031 |
|---|---|
| Brief Title: | A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048) |
| First Submitted : | February 3, 2015 |
| First Submitted that Met QC Criteria : | February 3, 2015 |
| First Posted : | February 6, 2015 (Estimate) |
| Results First Submitted : | January 29, 2020 |
| Results First Submitted that Met QC Criteria : | February 3, 2020 |
| Results First Posted : | February 17, 2020 |
| Last Update Submitted that Met QC Criteria : | February 8, 2024 |
| Last Update Posted : | February 12, 2024 |